Abstract:Acute myeloid leukemia (AML) is a blood system malignancy where sirtuin 5 (SIRT5) is abnormally expressed in AML cell lines. This study aimed to investigate the SIRT5 effects on the viability and apoptosis of AML cell lines. The mRNA and protein expression levels of succinylation regulatory enzyme in clinical samples and AML cell lines were detected by real-time quantitative polymerase chain reaction and western blotting while cell viability was measured using cell counting kit-8 assay. The apoptosis rate was assessed with flow cytometry. The interaction between SIRT5 and glycine decarboxylase (GLDC) was determined by co-immunoprecipitation and immunofluorescence staining techniques. Results indicated higher mRNA and protein expression levels of SIRT5 in clinical AML samples of AML than in normal subjects. Similarly, cell viability was inhibited, and apoptosis was promoted by downregulating SIRT5, in addition to inhibition of SIRT5-mediated GLDC succinylation. Moreover, rescue experiment results showed that GLDC reversed the effects of SIRT5 knockdown on cell viability and apoptosis. These results, in combination with SIRT5 and GLDC interactions, suggested that SIRT5 was involved in mediating AML development through GLDC succinylation. SIRT5 inhibits GLDC succinylation to promote viability and inhibit apoptosis of AML cells, suggesting that SIRT5 encourages the development of AML.

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the mechanism of Sirtuin 5 (SIRT5) in the survival and apoptosis of acute myeloid leukemia (AML) cells. Specifically, the researchers aim to verify whether SIRT5 affects the survival and apoptosis of AML cells by regulating the succinylation modification of glycine decarboxylase (GLDC). ### Main Research Questions: 1. **Expression of SIRT5 in AML**: Investigate whether the expression level of SIRT5 is abnormal in clinical samples from AML patients. 2. **Impact of SIRT5 on AML cell survival and apoptosis**: Observe the effects on AML cell survival and apoptosis by downregulating SIRT5 expression. 3. **Interaction between SIRT5 and GLDC**: Explore whether SIRT5 affects the survival and apoptosis of AML cells by regulating the succinylation modification of GLDC. 4. **Functional changes of GLDC under SIRT5 regulation**: Observe the impact on AML cell survival and apoptosis after SIRT5 knockdown by overexpressing GLDC. ### Research Background: - Acute myeloid leukemia (AML) is a malignant tumor of the hematopoietic system characterized by the unlimited clonal proliferation and loss of differentiation of bone marrow hematopoietic stem cells. - Current clinical treatments for AML include radiotherapy, chemotherapy, and surgery, but these methods have high side effects and are prone to drug resistance. - Succinylation modification is a novel post-translational modification of proteins, widely present in cells, and involved in various life activities. - SIRT5 is one of the desuccinylases located in the mitochondria, belonging to the evolutionarily conserved Sirtuin family, with unique enzymatic activity. - Glycine decarboxylase (GLDC) is overexpressed in various cancers and is involved in tumor growth and progression. ### Research Objectives: - Explore the specific mechanism of SIRT5 in the development of AML, particularly its role in affecting AML cell survival and apoptosis by regulating the succinylation modification of GLDC. - Provide new potential targets for the targeted therapy of AML to improve the prognosis of AML. Through these studies, the authors hope to reveal the important role of SIRT5 in AML and provide a scientific basis for developing new therapeutic strategies.

Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase